About Enhabit Inc.
Ticker
info
EHAB
Trading on
info
NYSE
ISIN
info
US29332G1022
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Headquarters
info
6688 N. Central Expressway, Dallas, TX, United States, 75206
Employees
info
10,700
Website
info
ehab.com
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Metrics
BasicAdvanced
Market cap
info
$552M
P/E ratio
info
-
EPS
info
-$0.24
Dividend Yield
info
0.00%
Beta
info
1.28
Forward P/E ratio
info
20.88
EBIDTA
info
$87.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$552M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
20.88
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.53
Price to book
info
0.97
Earnings
EPS
info
-$0.24
EPS estimate (current quarter)
info
$0.12
EPS estimate (next quarter)
info
$0.14
EBITDA
info
$87.4M
Revenues (TTM)
info
$1.05B
Revenues per share (TTM)
info
$20.69
Technicals
Beta
info
1.28
52-week High
info
$11.27
52-week Low
info
$6.47
50-day moving average
info
$9.10
200-day moving average
info
$8.53
Short ratio
info
3.34
Short %
info
3.29%
Management effectiveness
ROE (TTM)
info
-1.69%
ROA (TTM)
info
3.06%
Profit margin
info
-1.14%
Gross profit margin
info
$513M
Operating margin
info
6.37%
Growth
Quarterly earnings growth (YoY)
info
8,667.50%
Quarterly revenue growth (YoY)
info
3.90%
Share stats
Outstanding Shares
info
50.6M
Float
info
39.8M
Insiders %
info
3.44%
Institutions %
info
103.64%
Analyst Insights & forecasts
info

20% Buy

80% Hold

0% Sell

Based on information from 5 analysts.

Average price target

info
$11.20
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.04
$0.05
-27.14%
Q4 • 24Missed
$0.10
$0.06
60.26%
Q1 • 25Beat
$0.10
$0.10
-
Q2 • 25Beat
$0.17
$0.12
41.67%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$266M
$5.2M
1.95%
Q2 • 25
$264M
$11.1M
4.21%
Q3 • 25
-0.94%
113.46%
115.49%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.23B
$643M
52.43%
Q2 • 25
$1.23B
$631M
51.37%
Q3 • 25
0.24%
-1.79%
-2.02%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$10.6M
$-1.8M
$-10.7M
$8.7M
Q2 • 25
$37.8M
$-1.4M
$-16.4M
$36.2M
Q3 • 25
256.60%
-22.22%
53.27%
316.09%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Enhabit Inc. share?
Collapse

Enhabit Inc. shares are currently traded for undefined per share.

How many shares does Enhabit Inc. have?
Collapse

Enhabit Inc. currently has 50.6M shares.

Does Enhabit Inc. pay dividends?
Collapse

No, Enhabit Inc. doesn't pay dividends.

What is Enhabit Inc. 52 week high?
Collapse

Enhabit Inc. 52 week high is $11.27.

What is Enhabit Inc. 52 week low?
Collapse

Enhabit Inc. 52 week low is $6.47.

What is the 200-day moving average of Enhabit Inc.?
Collapse

Enhabit Inc. 200-day moving average is $8.53.

Who is Enhabit Inc. CEO?
Collapse

The CEO of Enhabit Inc. is Barbara Ann Jacobsmeyer B.S., M.A., P.T..

How many employees Enhabit Inc. has?
Collapse

Enhabit Inc. has 10,700 employees.

What is the market cap of Enhabit Inc.?
Collapse

The market cap of Enhabit Inc. is $552M.

What is the P/E of Enhabit Inc.?
Collapse

The current P/E of Enhabit Inc. is null.

What is the EPS of Enhabit Inc.?
Collapse

The EPS of Enhabit Inc. is -$0.24.

What is the PEG Ratio of Enhabit Inc.?
Collapse

The PEG Ratio of Enhabit Inc. is null.

What do analysts say about Enhabit Inc.?
Collapse

According to the analysts Enhabit Inc. is considered a hold.